IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 14 analysts with an average price target of $28.4. This is a potential upside of $13.2 (86.84%) from yesterday's end of day stock price of $15.2.

Immunovant 's activity chart (see below) currently has 74 price targets and 106 ratings on display. The stock rating distribution of IMVT is 98.21% BUY and 1.79% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.01% with an average time for these price targets to be met of 179.53 days.

Highest price target for IMVT is $53, Lowest price target is $20, average price target is $37.08.

Most recent stock forecast was given by JASON GERBERRY from BAML on 20-Mar-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 55 are a BUY (98.21%), 1 are a HOLD (1.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$14.63 (79.64%)

$45

12 days ago
(20-Mar-2025)

1/3 (33.33%)

$13.31 (67.60%)

126

Buy

12 days ago
(20-Mar-2025)

3/7 (42.86%)

$24.48 (125.41%)

119

Buy

$51

$32.63 (177.63%)

$51

13 days ago
(19-Mar-2025)

11/20 (55%)

$32.12 (170.13%)

268

Hold

$20

$1.63 (8.87%)

$32

29 days ago
(03-Mar-2025)

6/6 (100%)

$-0.6 (-2.91%)

95

Buy

$45

$26.63 (144.96%)

$48

3 months 13 days ago
(19-Dec-2024)

4/8 (50%)

$19.34 (75.37%)

371

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.53 days on average for the stock forecasts to be realized with a an average price target met ratio 59.01

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 7 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $38.63

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$11.37

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?